News Archive
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-Regulated IL-2 Program by Roche
“Given Roche’s expertise in this field and broad capabilities in oncology, we believe they are a perfect choice for taking this important program forward…”
Targeted Molecule Therapeutics and the Role of Cytokines in Oncological Treatment with John Mulligan
Finding Genius
Feb 14, 2022
Podcast